Nobel Prize winners raise alarm over genetic engineering of humans.
A roundup of the most interesting stories from other sites, collected by the staff at MIT Technology Review.
Advertisement
Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.
Peter Thiel was the first large investor in Facebook. Now he’s turning his investing skills to biotechnology.
Scientists are developing ways to edit the DNA of tomorrow’s children. Should they stop before it’s too late?
If you would like to update the frequency or type of newsletters received, please edit your newsletter preferences or unsubscribe from all MIT Technology Review communications.MIT Technology ReviewOne Main StreetCambridge, MA 02142
